Literature DB >> 20553282

Stent thrombosis--risk assessment and prevention.

Zuzana Motovska1, Jiri Knot, Petr Widimsky.   

Abstract

The development and use of stents has made percutaneous coronary intervention an effective (less restenosis), safe (treatment of emergency vessel closure during balloon angioplasty), and applicable (stents were developed for lesions of tortuous anatomy and complex situations) revascularization method. These features have firmly established stenting as first-line therapy in coronary revascularization. This life-saving device carries, however, the risk of a life-threatening complication--stent thrombosis. The article summarizes the facts about the incidence, histopathology, and risk factors of bare-metal as well as drug-eluting stent thrombosis. Future directions in reducing the incidence of stent thrombosis are also outlined.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553282     DOI: 10.1111/j.1755-5922.2010.00186.x

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  9 in total

1.  Atrial fibrillation and percutaneous coronary intervention: stroke, thrombosis, and bleeding.

Authors:  Antonio Gutierrez; Sunil V Rao
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-06

2.  Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD.

Authors:  Joshua A Walker; Sean Richards; Stephen A Whelan; Sung Bok Yoo; Teresa L Russell; Nkiruka Arinze; Saran Lotfollahzadeh; Marc A Napoleon; Mostafa Belghasem; Norman Lee; Laura M Dember; Katya Ravid; Vipul C Chitalia
Journal:  J Am Soc Nephrol       Date:  2021-11       Impact factor: 10.121

3.  Stent thrombosis during COVID-19 pandemic: A case series.

Authors:  Mohammad Montaseri; Reza Golchin Vafa; Armin Attar; Seyed Ali Hosseini; Javad Kojuri
Journal:  Clin Case Rep       Date:  2022-05-18

Review 4.  Thrombosis in the uremic milieu--emerging role of "thrombolome".

Authors:  Moshe Shashar; Jean Francis; Vipul Chitalia
Journal:  Semin Dial       Date:  2014-06-24       Impact factor: 3.455

Review 5.  Intermittent claudication: new targets for drug development.

Authors:  Eric P Brass
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

6.  Coronary stent stenosis in acute myocardial infarction.

Authors:  Marcelo Rodrigues Bacci; Janaina Aparecida Boide Santos; Leonardo Fernando Ferrari Nogueira
Journal:  BMJ Case Rep       Date:  2013-05-20

7.  Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.

Authors:  Vipul C Chitalia; Sowmya Shivanna; Jordi Martorell; Mercedes Balcells; Irene Bosch; Kumaran Kolandaivelu; Elazer R Edelman
Journal:  Circulation       Date:  2012-12-25       Impact factor: 29.690

Review 8.  Prevention of stent thrombosis: challenges and solutions.

Authors:  Risheen Reejhsinghani; Amir S Lotfi
Journal:  Vasc Health Risk Manag       Date:  2015-01-27

9.  Short- and Long-term Outcomes in Patients with Connective Tissue Diseases Undergoing Percutaneous Coronary Intervention.

Authors:  Li Zhou; Hui Chen; Wei-Ping Li; Hong-Li Gao; Dong-Bao Li; Hui-Qiang Zhao; Dao-Kuo Yao; Hong-Wei Li
Journal:  Chin Med J (Engl)       Date:  2016-04-05       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.